Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -83,865 | -65,373 | -28,720 |
| Depreciation Amortization | 2,597 | 2,431 | 2,266 |
| Accounts receivable | N/A | 1,034 | -510 |
| Accounts payable and accrued liabilities | -760 | 519 | -408 |
| Other Working Capital | -424 | -325 | -28,280 |
| Other Operating Activity | 5,701 | 6,682 | 8,222 |
| Operating Cash Flow | $-76,751 | $-55,032 | $-47,430 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 65,998 | -119,821 | -22,717 |
| PPE Investments | -2,587 | -642 | -3,258 |
| Investing Cash Flow | $63,411 | $-120,463 | $-25,975 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 24,393 |
| Debt Repayment | -132 | -149 | N/A |
| Common Stock Issued | 371 | 166,558 | 10 |
| Common Stock Repurchased | N/A | N/A | -12 |
| Other Financing Activity | -230 | -4,183 | 0 |
| Financing Cash Flow | $9 | $162,226 | $24,391 |
| Beginning Cash Position | 40,493 | 53,762 | 102,776 |
| End Cash Position | 27,162 | 40,493 | 53,762 |
| Net Cash Flow | $-13,331 | $-13,269 | $-49,014 |
| Free Cash Flow | |||
| Operating Cash Flow | -76,751 | -55,032 | -47,430 |
| Capital Expenditure | -2,587 | -642 | -3,258 |
| Free Cash Flow | -79,338 | -55,674 | -50,688 |